Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Clinical trial NCT05061550 · RECRUITING
Trial details
- NCT number
- NCT05061550
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2030-05-28
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.